Shellmycin A-D, Novel Bioactive Tetrahydroanthra-γ-Pyrone Antibiotics from Marine Streptomyces sp. Shell-016

Area of Science:

• Marine Natural Products Chemistry
• Microbial Secondary Metabolites
• Drug Discovery

Background:

• Marine microorganisms, particularly *Streptomyces* species, are prolific sources of novel bioactive compounds.
• The Binzhou Shell Dike Island and Wetland National Nature Reserve in China is a unique ecosystem with potential for discovering new bioactive natural products.
• Tetrahydroanthra-γ-pyrone scaffolds are known to possess diverse biological activities.

Purpose of the Study:

• To isolate and characterize novel bioactive compounds from marine *Streptomyces* sp. shell-016.
• To evaluate the cytotoxic potential of the isolated compounds against various cancer cell lines.
• To elucidate the structure-activity relationships and propose biosynthetic pathways for the new compounds.

Main Methods:

• Isolation of compounds using chromatographic techniques.
• Structure elucidation via 1D and 2D Nuclear Magnetic Resonance (NMR) spectroscopy and High-Resolution Mass Spectrometry (HR-MS).
• Confirmation of absolute configuration using single crystal X-ray diffraction.
• Cytotoxicity assays against a panel of human cancer cell lines.
• Analysis of structure-activity relationships (SAR) and biosynthetic pathway reconstruction.

Main Results:

• Four novel tetrahydroanthra-γ-pyrone compounds, named shellmycin A-D (1-4), were successfully isolated from *Streptomyces* sp. shell-016.
• The structures of compounds 1-4 were fully elucidated, with the absolute configuration of compound 1 confirmed by X-ray crystallography. Compounds 3 and 4 were identified as stereoisomers.
• Shellmycin A-D (1-4) demonstrated significant cytotoxic activity against five tested cancer cell lines, with IC50 values ranging from 0.69 μM to 26.3 μM.

Conclusions:

• The marine-derived *Streptomyces* sp. shell-016 yielded four novel cytotoxic tetrahydroanthra-γ-pyrones, shellmycin A-D.
• These compounds represent promising leads for the development of new anticancer agents.
• Further investigation into their mechanisms of action and biosynthetic pathways is warranted.